COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
8.75
0.00 (0.00%)
Oct 1, 2026, 2:13 PM EST

COSCIENS Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
6.55-10.36-15.31-3.493.45-8.37
Depreciation & Amortization
1.251.191.611.441.470.15
Loss (Gain) From Sale of Assets
-11.26-----0
Asset Writedown & Restructuring Costs
0.240.244.26---
Stock-Based Compensation
0.07-0.010.460.190.070.31
Other Operating Activities
-0.340.18-3.07-0.791.18-3.17
Change in Accounts Receivable
-0.351.15-1.681.86-0.610.12
Change in Inventory
0.671.421.11-1.16-1.09-0.06
Change in Accounts Payable
-1.44-2.45-0.82-0.420.810.63
Change in Unearned Revenue
-0.010.22--3.01
Change in Income Taxes
------0.11
Change in Other Net Operating Assets
0.870.17-0.59-0.130.02-1.1
Operating Cash Flow
-3.72-8.47-14.57-2.585.23-8.58
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.05-0.71-1.16-0.72-0.3-0.03
Sale of Property, Plant & Equipment
0.260.24---0
Cash Acquisitions
--26.04---
Sale (Purchase) of Intangibles
------0.61
Other Investing Activities
-0.200.21-0.01--0.02
Investing Cash Flow
-0.02-0.4625.08-0.73-0.3-0.66

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.37-0.42-0.37-0.33-0.13
Lease Payments
-0.24-0.37-0.42-0.37-0.33-0.13
Net Debt Issued (Repaid)
-0.24-0.37-0.42-0.37-0.33-0.13
Issuance of Common Stock
---0.010.0654.29
Other Financing Activities
--0.04-0.17---3.12
Financing Cash Flow
-0.24-0.41-0.59-0.36-0.2751.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.070.25-0.210.16-0.63-0.77
Net Cash Flow
-4.05-9.099.72-3.514.0341.03

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.78-9.18-15.73-3.34.93-8.61
Free Cash Flow Growth
------
Free Cash Flow Margin
-43.28%-122.42%-164.07%-46.26%33.80%-163.71%
Free Cash Flow Per Share
-3.58-8.70-18.28-5.377.97-22.48
Levered Free Cash Flow
-3.29-6.32-2.44-7.73.78-4.75
Unlevered Free Cash Flow
-3.17-6.21-2.36-7.613.87-4.75
Free Cash Flow After Leases
-4.02-9.54-16.15-3.674.6-8.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
-----1.61
Change in Working Capital
-0.250.29-2.510.06-0.942.5